On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Kurt Miller

ResearcherPublications, citations & collaboration network

Kurt Miller is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Kurt Miller have?

ScholarIQindexed works

Kurt Miller has 510 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Kurt Miller have?

ScholarIQcitation count

Kurt Miller has 27,666 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Kurt Miller?

ScholarIQh-index

Kurt Miller has an h-index of 73 in OpenAlex.

What is the i10-index of Kurt Miller?

ScholarIQi10-index

Kurt Miller has an i10-index of 254 in OpenAlex.

What is the OpenAlex record for Kurt Miller?

ScholarIQopenalex

The OpenAlex for Kurt Miller is on the source record.

What are the most-cited papers on Kurt Miller?

ScholarIQmost cited works
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Howard I. Scher, Karim Fizazi, Fred Saad, Mary‐Ellen Taplin, Cora N. Sternberg, Kurt Miller, Ronald de Wit, Peter F.A. Mulders, Kim N., Neal D. Shore, Andrew J. Armstrong, Thomas W. Flaig, Aude Fléchon, Paul N. Mainwaring, Mark T. Fleming, John D. Hainsworth, Mohammad Hirmand, Bryan Selby, Lynn Seely, Johann S. de Bono
New England Journal of Medicine. 20124,604 CitationsOPEN ACCESS
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
Tomasz M. Beer, Andrew J. Armstrong, Dana E. Rathkopf, Yohann Loriot, Cora N. Sternberg, Celestia S. Higano, Peter Iversen, Suman Bhattacharya, Joan Carles, Simon Chowdhury, Ian D. Davis, Johann S. de Bono, Christopher P. Evans, Karim Fizazi, Anthony M. Joshua, Choung‐Soo Kim, Go Kimura, Paul N. Mainwaring, Harry H. Mansbach, Kurt Miller, Sarah B. Noonberg, Frank Perabo, De Phung, Fred Saad, Howard I. Scher, Mary‐Ellen Taplin, Peter Venner, Bertrand Tombal
New England Journal of Medicine. 20143,057 CitationsOPEN ACCESS
Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial
Matthew R. Smith, Chris Parker, Fred Saad, Kurt Miller, Bertrand Tombal, Quan Sing Ng, Martin Boegemann, Vsevolod Matveev, Josep M. Piulats, Luis Eduardo Rosa Zucca, Oleg Karyakin, Go Kimura, Nobuaki Matsubara, William Carlos Nahas, Franco Nolè, Eli Rosenbaum, Axel Heidenreich, Yoshiyuki Kakehi, Amily Zhang, Heiko Krissel, Michael Teufel, Junwu Shen, Volker Jean Wagner, Celestia S. Higano
The Lancet Oncology. 2019407 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · free account